Cytosorbents (CTSO) Other Non-Current Assets (2010 - 2026)
Cytosorbents posted quarterly Other Non-Current Assets of $52000.0 for Q1 2026, down 98.62% year-on-year from $3.8 million in Q1 2025, and down 1.89% on a QoQ basis from $53000.0 in Q4 2025.
Cytosorbents (CTSO) has 17 years of Other Non-Current Assets data on file, last reported at $52000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets fell 98.62% year-over-year to $52000.0; the trailing twelve-month figure through Mar 2026 stood at $52000.0 (down 98.62% YoY), and the FY2025 full-year result was $53000.0, up 6.0% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $52000.0, down from $53000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $6.5 million in Q2 2024 and bottomed at $50000.0 in Q4 2024.
- The 5-year median for Other Non-Current Assets is $1.7 million (2022), against an average of $2.2 million.
- The widest annual swing landed in 2024, when Other Non-Current Assets soared 284.24%; it then tumbled 98.62% in 2026.
- A 5-year view of Other Non-Current Assets shows it stood at $4.4 million in 2022, then sank by 66.56% to $1.5 million in 2023, then tumbled by 96.63% to $50000.0 in 2024, then grew by 6.0% to $53000.0 in 2025, then dropped by 1.89% to $52000.0 in 2026.
- The last three Other Non-Current Assets figures came in at $52000.0 (Q1 2026), $53000.0 (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 4.04 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 140.49 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 285.90 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 211.40 Mn |
| 10 | Cytosorbents | 28.81 Mn | 24.01 Mn | 6.13 Mn | 52,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 52,000.00 |
| Dec 31, 2025 | 53,000.00 |
| Sep 30, 2025 | 1.52 Mn |
| Jun 30, 2025 | 3.79 Mn |
| Mar 31, 2025 | 3.76 Mn |
| Dec 31, 2024 | 50,000.00 |
| Sep 30, 2024 | 3.80 Mn |
| Jun 30, 2024 | 6.48 Mn |
| Mar 31, 2024 | 1.48 Mn |
| Dec 31, 2023 | 1.48 Mn |
| Sep 30, 2023 | 1.69 Mn |
| Jun 30, 2023 | 1.69 Mn |
| Mar 31, 2023 | 1.69 Mn |
| Dec 31, 2022 | 4.44 Mn |
| Sep 30, 2022 | 1.69 Mn |
| Jun 30, 2022 | 1.69 Mn |
| Mar 31, 2022 | 1.69 Mn |
| Dec 31, 2021 | 1.69 Mn |
| Sep 30, 2021 | 4.87 Mn |
| Jun 30, 2021 | 4.79 Mn |
| Mar 31, 2021 | 4.52 Mn |
| Dec 31, 2020 | 54,000.00 |
| Sep 30, 2020 | 4.27 Mn |
| Jun 30, 2020 | 4.13 Mn |
| Mar 31, 2020 | 3.73 Mn |
| Dec 31, 2019 | 123,482.00 |
| Sep 30, 2019 | 3.24 Mn |
| Jun 30, 2019 | 3.08 Mn |
| Mar 31, 2019 | 2.91 Mn |
| Dec 31, 2018 | 2.75 Mn |
| Sep 30, 2018 | 2.62 Mn |
| Jun 30, 2018 | 2.40 Mn |
| Mar 31, 2018 | 2.18 Mn |
| Dec 31, 2017 | 1.96 Mn |
| Sep 30, 2017 | 1.80 Mn |
| Jun 30, 2017 | 1.62 Mn |
| Mar 31, 2017 | 1.42 Mn |
| Dec 31, 2016 | 1.30 Mn |
| Sep 30, 2016 | 1.18 Mn |
| Jun 30, 2016 | 1.04 Mn |
| Mar 31, 2016 | 901,625.00 |
| Dec 31, 2015 | 836,749.00 |
| Dec 31, 2014 | 615,798.00 |
| Sep 30, 2014 | 481,017.00 |
| Jun 30, 2014 | 462,588.00 |
| Mar 31, 2014 | 409,687.00 |
| Dec 31, 2013 | 414,375.00 |
| Sep 30, 2013 | 251,409.00 |
| Jun 30, 2013 | 251,432.00 |
| Mar 31, 2013 | 257,547.00 |
| Dec 31, 2012 | 254,220.00 |
| Sep 30, 2012 | 278,483.00 |
| Jun 30, 2012 | 287,225.00 |
| Mar 31, 2012 | 277,411.00 |
| Dec 31, 2011 | 269,994.00 |
| Sep 30, 2011 | 273,857.00 |
| Jun 30, 2011 | 271,235.00 |
| Dec 31, 2010 | 267,575.00 |